KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Other financing activities (2016 - 2026)

Amgen has reported Other financing activities over the past 18 years, most recently at -$104.0 million for Q1 2026.

  • For Q1 2026, Other financing activities fell 285.19% year-over-year to -$104.0 million; the TTM value through Mar 2026 reached -$129.0 million, down 111.48%, while the annual FY2025 figure was -$52.0 million, 58.06% up from the prior year.
  • Other financing activities for Q1 2026 was -$104.0 million at Amgen, down from $57.0 million in the prior quarter.
  • Over five years, Other financing activities peaked at $57.0 million in Q4 2025 and troughed at -$104.0 million in Q1 2026.
  • A 5-year average of -$26.8 million and a median of -$26.0 million in 2022 define the central range for Other financing activities.
  • Biggest five-year swings in Other financing activities: surged 2950.0% in 2025 and later crashed 285.19% in 2026.
  • Year by year, Other financing activities stood at $10.0 million in 2022, then tumbled by 150.0% to -$5.0 million in 2023, then soared by 60.0% to -$2.0 million in 2024, then surged by 2950.0% to $57.0 million in 2025, then crashed by 282.46% to -$104.0 million in 2026.
  • Business Quant data shows Other financing activities for AMGN at -$104.0 million in Q1 2026, $57.0 million in Q4 2025, and $10.0 million in Q3 2025.